Public Service Review's Caroline Pennington describes how the IMI's 4th Call is focusing on new methods of developing safer and more effective treatments for patients
The Innovative Medicines Initiative (IMI) has recently launched a 4th Call for proposals to revolutionise collaborative research in seven new major public health topics, going out to people, organisations and enterprises interested in participating in future IMI projects. The EU has confirmed it will contribute up to €105m to projects in the 4th Call, and funding will be matched with contributions from the European Federation of Pharmaceutical Industries and Associations (EFPIA).
To read the full, original article click on this link: Revolutionising medical treatment - Public Service
